Patents Assigned to Ascentgene, Inc.
  • Compositions and methods for the diagnosis, treatment and prevention of neoplastic and neurological disorders
    Patent number: 12012415
    Abstract: The invention is directed to composition and methods for the diagnosis, treatment and prevention of various disorders including but not limited to cancer and neurological disorders. In particular, the invention is directed to compositions and methods for the inhibition of PC4.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: June 18, 2024
    Assignee: AscentGene, Inc.
    Inventor: Hui Ge
  • Compositions and Methods for the Diagnosis, Treatment and Prevention of Neoplastic and Neurological Disorders
    Publication number: 20210253590
    Abstract: The invention is directed to composition and methods for the diagnosis, treatment and prevention of various disorders including but not limited to cancer and neurological disorders. In particular, the invention is directed to compositions and methods for the inhibition of PC4.
    Type: Application
    Filed: June 27, 2019
    Publication date: August 19, 2021
    Applicant: AscentGene, Inc.
    Inventor: Hui Ge
  • Method and Composition for Cancer Diagnosis and Treatment
    Publication number: 20120135879
    Abstract: Methods and compositions for inhibiting the onset of cancer, and cancer diagnosis and treatment are provided. The treatment method comprises inhibiting the level or function of transcriptional positive factor 4 (PC4). Also provided are methods of screening for cancer inhibition agents based on inhibition of PC4 expression or function.
    Type: Application
    Filed: November 23, 2011
    Publication date: May 31, 2012
    Applicant: ASCENTGENE, INC.
    Inventor: Hui Ge
  • Method and composition for cancer diagnosis and treatment
    Patent number: 8076061
    Abstract: Methods and compositions for inhibiting the onset of cancer, and cancer diagnosis and treatment are provided. The treatment method comprises inhibiting the level or function of transcriptional positive factor 4 (PC4). Also provided are methods of screening for cancer inhibition agents based on inhibition of PC4 expression or function.
    Type: Grant
    Filed: September 4, 2008
    Date of Patent: December 13, 2011
    Assignee: Ascentgene, Inc.
    Inventor: Hui Ge